Abstract:Background Periodontal ligament stem cells (PDLSCs) represent a promising source for the regeneration of periodontal tissues. However, these cells may experience functional alterations during in vitro expansion and culture, as well as under inflammatory conditions. In this study, we investigated AS2863619 (AS), a small molecule drug with potential applications in immune disease research, to evaluate its effects on the osteogenic potential of PDLSCs and to elucidate the underlying mechanisms of action. Methods The effect of AS on the proliferation of PDLSCs was evaluated using a CCK-8 assay. The osteogenic potential of PDLSCs was assessed through alkaline phosphatase (ALP) activity staining or Alizarin Red S (ARS) staining to detect mineralized nodules. Inflammatory injury in PDLSCs was induced by treating them with recombinant human tumor necrosis factor-alpha (rhTNF-α) . Transcriptome sequencing was employed to investigate the potential target of AS for rescuing osteogenic differentiation from inflammatory injury. Real-time quantitative polymerase chain reaction (RT-qPCR) and western blot analysis were conducted to determine the expression levels of osteogenic gene markers and associated signaling pathways. Various small molecule inhibitors, agonists, and recombinant proteins were utilized to modulate relevant signaling pathways as specified in the text. Results The proliferation of PDLSCs was inhibited by AS at 250 nM after 1 day of culture, whereas AS at 125 nM inhibited their proliferation after 3 and 5 days of culture. Additionally, AS significantly enhanced the ALP activity of PDLSCs and accelerated the formation time of mineralized nodules, while suppressing their adipogenic differentiation ability. Furthermore, AS promoted the levels of bone morphogenetic protein (BMP)2 and phosphorylated (p)-SMAD1/5 without significant effects on p-ERK, p-P38, and p-JNK levels. Moreover, AS effectively augmented rhTNF-α-inhibited ALP activity in PDLSCs and attenuated rhTNF-α-induced components involved in retinoic acid-inducible gene I (RIG-I)-like receptor signaling pathway including RIG-I, MDA5, and ISG15. Conclusions AS is a potent small molecule that effectively enhances the osteogenic potential of PDLSCs, potentially by augmenting BMP2/SMAD signaling. Additionally, AS significantly improves the inflammation-induced impairment of osteogenic potential in PDLSCs and may contribute to osteogenic rescue through inhibition of rhTNF-α-induced RIG-I-like receptor signaling pathway.

Recombinant Human Amelogenin Reverses Osteogenesis Suppression Induced By An Inflammatory Microenvironment In Human Periodontal Ligament Cells

Decellularized Matrix Could Affect the Proliferation and Differentiation of Periodontal Ligament Stem Cells in Vitro

Downregulation of Rankl and Rankl/Osteoprotegerin Ratio in Human Periodontal Ligament Cells During Their Osteogenic Differentiation

HOXA10 Inhibit the Osteogenic Differentiation of Periodontal Ligament Stem Cells by Regulating Β-Catenin Localization and DKK1 Expression

Effects of mechanical vibration on proliferation and osteogenic differentiation of human periodontal ligament stem cells.

Different Effects of 25-Kda Amelogenin on the Proliferation, Attachment and Migration of Various Periodontal Cells

The Effect of Inflammation on Proliferation and Osteogenic Differentiation of Periodontal Ligament Cells

Human β-defensin 3 gene modification promotes the osteogenic differentiation of human periodontal ligament cells and bone repair in periodontitis

Experimental Study on Human Periodontal Ligament Cells Transfected with Human Amelogenin Gene

A Potent Small Molecule, AS2863619, Enhances the Osteogenic Potential and Ameliorates the Inflammation-Induced Impairment of Osteogenesis in Periodontal Ligament Stem Cells

Enhanced Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Suberoylanilide Hydroxamic Acid

Effect of enamel matrix derivatives on the differentiation and proliferation of human periodontal ligament stem cells

The Effects of Recombinant Porcine Amelogenin on Human Gingival Epithelial Cells

1,25(OH)2D3 Supports the Osteogenic Differentiation of Hpdlscs under Inflammatory Conditions Through Inhibiting PLAP-1 Expression Transcriptionally.

Analogous effects of recombinant human full-length amelogenin expressed by Pichia pastoris yeast and enamel matrix derivative in vitro.

The effects of A20 -knockdown on the proliferation and differentiation of human dental pulp stem cells in the inflammatory environment

Wnt3a Promotes Osteogenic Differentiation of Periodontal Ligament Stem Cell and Regeneration of Alveolar Bone in Experimental Periodontitis

Human amnion-derived mesenchymal stem cells promote osteogenic differentiation of lipopolysaccharide-induced human bone marrow mesenchymal stem cells via ANRIL/miR-125a/APC axis

Dissecting specific Wnt components governing osteogenic differentiation potential by human periodontal ligament stem cells through interleukin-6

[The Effect of Rham and EMPs on Promoting Differentiation of Hbmscs into Osteoblasts].

Role of Micro 34a in Induced-mineralization of Human Periodontal Ligament Cells